Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorAalborg University Hospital
About this trial
Predicting early onset neuropathy in people with type 1 diabetes
Eligibility criteria
Qualifiers
Men and women aged 18-80 years
Diagnosed with diabetes (of any type)
No clinically established diabetic peripheral neuropathy at inclusion
Disqualifiers
Alcohol or drug abuse within the last year (prior to inclusion)
Chemotherapy (prior or within study period) or experimental medicine
Severe vitamin deficiencies
Inability to understand or comply with the examinations
Trial design
Treatments tested in this trial
- Skin biopsies with quantification of intra-epidermal nerve fibre density
- Perception Threshold Tracking
- Thermal perception thresholds
- Corneal confocal Microscopy
- MRI
- Nerve conduction studies
- Composite scores and questionnaires
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Aalborg University Hospital
Lead sponsor
Aalborg University
Collaborator
University of Aarhus
Collaborator
Source ClinicalTrials.gov